Researchers have claimed that a drug that lowers blood sugar levels for people with Type 2 diabetes may also significant...
Enzychem Lifesciences, Corp., a Korea based life sciences company announced the initiation of the dose-escalation stage ...
NanoBio Corporation, a US based biopharmaceutical company focused on developing and commercializing vaccines and anti-in...
Singapore - During a symposium, titled "Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with ...
The Scripps Research Institute (TSRI) and ShangPharma Innovation, Inc. (SPII) announced a strategic collaboration to acc...
Singapore - BD (Becton, Dickinson and Company), a global medical technology company, announced 510 (k) clearance from th...
Dr Subir Basak Chief Business Officer, GVK Biosciences Over the last two decades, the Pharmaceutical industry has seen ...
Singapore - Novo Nordisk, a US based global healthcare company announced that the U.S. Food and Drug Administration (FDA...
Singapore: Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to...
Singapore: Symic Bio, a US based biopharmaceutical company announced the successful completion of a $30 million&nbs...
Singapore: French drug giant Sanofi has inked a $273 million research deal and licence option agreement in metabolic dis...
After nearly two decades FDA has finally approved a drug for the treatment of amyotrophic lateral sclerosis (ALS). The d...
Indian scientists have found that a plant-derived substance called chalcone can be used to make an effective anti-diabet...
Foamix Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company focused on developing and commercializing...
According to the new study conducted by researchers of the University of Bern in Switzerland 'harmless' bacteria found i...
Global pharmaceutical major Glenmark Pharmaceuticals has received the US Food and Drug Administration (USFDA) approval f...
Singapore: Asceneuron, an emerging leader in the development of innovative small molecules for neurodegenerative disease...
TB Alliance and Medicines Patent Pool announced a licensing agreement for the clinical development of sutezolid. It is a...
